Taiwan-China to collaborate on new drug discovery

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2014

Singapore: The Mainland Affairs Council (MAC) recently announced that Taiwan and China have reached a concrete consensus...Read more

Eliquis approved in EU for stroke prevention

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Nov, 2012

Singapore: European Commission has approved Eliquis (apixaban) for prevention of stroke and systemic embolism in adult p...Read more

Lilly phase III lung cancer study meets endpoint

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2013

Singapore: Eli Lilly and Company completed its phase III study regarding stage IV metastatic squamous non-small cell lun...Read more

Dong-A Pharma gets positive trial results for Evogliptin

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jan, 2013

Singapore: South Korea's Dong-A Pharmaceutical announced positive top-line results from its phase II clinical trial of D...Read more

STA to commercialize leukemia drug in Australia

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2014

Singapore: US-based Ariad Pharmaceuticals has granted Specialised Therapeutics Australia (STA), a specialty pharmaceutic...Read more

Eisai, Santen enter agreement for new ophthalmic drugs

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2012

Singapore: Japan-based Eisai and Santen Pharmaceutical entered into an option agreement which grants Santen rights of ev...Read more

Takeda initiates Ph3 trial for Ixazomib in Asia

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 28 Jan, 2014

Singapore: Takeda Development Center Shanghai (TDC Shanghai) and Takeda Development Center Asia has commenced TOURMALINE...Read more

China plans to phase out mandatory cosmetics animal testing

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Nov, 2013

Singapore: China's Food and Drug Administration plans to remove its mandatory animal test requirements for domestically ...Read more

Shimadzu launches i-series of HPLC system in Singapore

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2014

Singapore: Japan-based global analytics technology provider, Shimadzu (Asia Pacific), has launched i-Series of new indus...Read more

HUYA, Changzhou to harbour biotech innovation

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2014

Singapore: China's HUYA Bioscience has struck a partnership with Changzhou Center for Biotech Development (CZCBD) to foc...Read more

CSL progresses on Novartis influenza vaccine biz acquisition

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2015

Singapore: Australia based drug development company, CSL, has secured the necessary approvals required to proceed with t...Read more

Bionomics initiaties trial of anxiety drug in France

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Feb, 2015

Singapore: Australia-based Bionomics has initiated a Phase 1b clinical trial in healthy volunteers of BNC210, the drug c...Read more

US FDA sets up task force for antibacterial drugs

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2012

Singapore: The US Food and Drug Administration has formed an internal task force that will support the development of ne...Read more

Gilead buys liver disease drug candidate at $470 mn

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2015

Singapore: In a bid to boost drug pipeline, Gilead Sciences has acquired Farnesoid X Receptor (FXR) program comprising s...Read more

FDA to review MSD's next blockbuster drug, Keytruda

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2015

Singapore: Global bio pharmaceutical company, Merck Sharp and Dohme, has received USFDA nod to review the supplemental b...Read more

Chipscren Biosciences receives CFDA nod

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jan, 2015

Singapore: A Chinese biotech firm, Chipscreen Biosciencees has received the China FDA nod for its flagship drug Epidaza ...Read more

Invion completes patient enrolment for asthma drug trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Nov, 2015

Singapore: Australian drug development company, Invion, has completed the enrolment in its phase II clinical trial of IN...Read more

Rate of drug approvals dips down: Nature Study

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 5 Comment | 10 Jan, 2014

Singapore: Nature Biotechnology has published a peer-reviewed paper co-authored by the Biotechnology Industry Organizati...Read more